QGS.

Fundrise's $VCX is a closed-end venture fund trading at $316, ~17x its Net Asset Value of ~$19. Gives you a sense of how badly the public wants exposure to companies like Anthropic that it holds.

🇺🇸Reuters reporting just now that EPA Administrator Lee Zeldin says U.S. biofuel blending quota announcement will be made "before the end of the month." This increases the odds that it coincides with the White House's celebration of agriculture event on Friday.

$SIVE is now up +73.78% today ($231M MC). As markets price in information synthesis of the next potential $LITE of photonics. If I had to explain the difference: One laser source in Lumentum primarily benefits from current optical bottlenecks. The other in $SIVE is for the upcoming CPO/Silicon Photonic bottleneck. Lumentum is largely benefiting right now from $NVDA and hyperscalers securing capacity of EML lasers for current pluggable optical transceivers cycles. As seen with the current EML bottleneck, hyperscalers are buying out any 800G/1.6T transceiver + upstream capacity from: - $AAOI (in-house) - $COHR, $LITE (EML lasers + design) -> $FN (assembly) - $COHR, $LITE (EML lasers) -> Innolight / Eoptolink What's next? Silicon Photonics and Co-Packaged Optics. The architectural shift to CPO requires massive arrays of high-power CW DFB lasers. And this would likely trigger a complete, sudden paradigm shift in volume demand. $SIVE benefits from InP CW DFB lasers for SiPh and CPO: The up and coming companies like: $AYAR, $POET source $SIVE lasers, but primarily do advanced packaging. Then they feed up to larger companies like $MRVL Celestial (that buy $POET's interposers). However, if you go upstream, the light source is $SIVE. CW DFB lasers are light engine ( $SIVE ); the silicon photonics package ( $POET and others) is how it gets transmitted. CPO scale is not there yet. But we know it's coming. And as seen with current optical transceiver cycles: - Light sources from $LITE and $COHR demand much higher valuations than companies like $FN that focus on advanced packaging. Markets have been focusing on $POET, but missed where they get the actual $LITE type light source for Starlight. The risks are present including facing multi-source competition with $LITE, $COHR, $AVGO, and others. So again, make sure to do your own research. But my argument against that: Sivers been early enough to tailor custom lasers to fit $POET, Ayar, and other specifications before they got popular (sort like the $POET to $MRVL Celestial analogy). There's volume risks as well: But the potential Win Semi qualification offsets that. Dilution risk to scale capacity, is always present with every early-stage company as well. I did my thesis on $LITE last year and still love the stock for Google TPU ramp/OCS. But this year, I'm focusing on: $SIVE, as my personal CW DFB laser exposure for the new photonics architectural shift. I’m sharing my own thoughts on capturing the rotation from the current EML cycle to the upcoming CW DFB/Silicon Photonics cycle.